FDA Relaxes Vaccine Storage Rules to Speed Up Rollout

February 26, 2021 by Daniel Mollenkamp
FDA Relaxes Vaccine Storage Rules to Speed Up Rollout
Empty vials of the Pfizer-BioNTech COVID-19 vaccine are seen at a vaccination center at the University of Nevada, Las Vegas in Las Vegas. (AP Photo/John Locher)

WASHINGTON – The Food and Drug Administration has relaxed the rules around storage and transportation for some coronavirus vaccines in order to speed up the vaccine rollout.

Frozen vials of Pfizer-BioNTech’s coronavirus vaccine will be allowed to be kept at “conventional temperatures” found in pharmaceutical freezers for up to two weeks, following data provided to the agency by the company. Typically, the FDA demands that undiluted vials be stored in an ultra-low temperature freezer between -80ºC to -60ºC (-112ºF to -76ºF), a written statement from the agency said. 

This will allow for more flexibility, according to the FDA. Health care providers will receive new fact sheets to reflect this update.

Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said that the data Pfizer provided to the agency proves that the vaccines will remain stable at these less extreme temperatures for the two-week time period.

“The alternative temperature for transportation and storage will help ease the burden of procuring ultra-low cold storage equipment for vaccination sites and should help to get vaccines to more sites,” Marks said in a written comment.

In the U.S., 68.27 million doses of the vaccine were administered as of Thursday, Feb. 25, according to data estimates affiliated with Oxford University. An estimated 13.8% of the country, or 46.07 million people, have received at least one dose of a coronavirus vaccine. 

The Pfizer vaccine got an emergency authorization from the FDA in December. An estimate provided by the Department of Health and Human Services reported that the U.S. had purchased about $6 billion worth of Pfizer’s coronavirus vaccine as of Feb. 11.

The FDA has relaxed restrictions and oversights during the coronavirus, which has caused researchers to warn that the situation will need to be revisited after the coronavirus crisis is over to avoid the risk of weakening patient safety in the country. At the moment, however, vaccine rollout is a top priority for the agency.

A+
a-
  • FDA
  • Food and Drug Administration
  • health
  • Pfizer-BioNTech
  • supply chain
  • Transportation
  • vaccine storage
  • vaccine supply chain
  • In The News

    Health

    Voting

    Health

    Biden Announcing New Rule to Protect Consumers Who Purchase Short-Term Health Insurance Plans

    President Joe Biden on Thursday announced new steps to protect consumers who buy short-term health insurance plans that critics say amount to junk. A... Read More

    President Joe Biden on Thursday announced new steps to protect consumers who buy short-term health insurance plans that critics say amount to junk. A new rule finalized by the Democratic president's administration will limit these plans to just three months. And the plans can only be renewed for a maximum... Read More

    March 27, 2024
    by Dan McCue
    One-Time Treatment Could Revitalize Immune Systems in the Elderly

    PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of... Read More

    PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of immune cell could potentially revitalize the immune systems of the elderly, helping their bodies better react to viral and bacterial threats. The research was carried out... Read More

    March 27, 2024
    by Dan McCue
    Insurers to Expand Access to ‘Navigation Services’ for Cancer Patients

    WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients... Read More

    WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients and their families navigate the myriad challenges that might arise during treatment for cancer and other serious illnesses. The insurers involved are Aetna; Blue Cross Blue... Read More

    Five Takeaways From the Abortion Pill Case Before US Supreme Court

    WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone,... Read More

    WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration. It's... Read More

    Biden and Harris Argue Democrats Will Preserve Health Care and Republicans Would Take It Away

    RALEIGH, N.C. (AP) — President Joe Biden and Vice President Kamala Harris on Tuesday promoted their health care agenda in... Read More

    RALEIGH, N.C. (AP) — President Joe Biden and Vice President Kamala Harris on Tuesday promoted their health care agenda in the battleground state of North Carolina, arguing that Democrats like themselves would preserve access to care while Republicans would reverse gains made over the past decade... Read More

    March 26, 2024
    by Tom Ramstack
    Supreme Court Skeptical of Ban on Abortion Pill Mifepristone

    WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access... Read More

    WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access to the abortion pill mifepristone despite objections from anti-abortion activists. The doctors and organizations who sued argued the Food and Drug Administration was wrong in granting... Read More

    News From The Well
    scroll top